Genomic structure and identification of novel mutations in Usherin, the gene responsible for Usher syndrome type IIa

被引:148
|
作者
Weston, MD
Eudy, JD
Fujita, S
Yao, SF
Usami, S
Cremers, C
Greenburg, J
Ramesar, R
Martini, A
Moller, C
Smith, RJ
Sumegi, J
Kimberling, WJ
机构
[1] Boys Town Natl Res Hosp, Dept Genet, Omaha, NE 68131 USA
[2] Univ Nebraska, Med Ctr, Monroe Meyer Inst Genet & Rehabil, Ctr Genet Mol, Omaha, NE USA
[3] Hirosaki Univ, Sch Med, Dept Otorhinolaryngol, Hirosaki, Aomori 036, Japan
[4] Shinshu Univ, Sch Med, Dept Otorhinolaryngol, Matsumoto, Nagano 390, Japan
[5] Katholieke Univ Nijmegen, Nijmegen, Netherlands
[6] Univ Cape Town, Sch Med, Dept Genet, ZA-7925 Cape Town, South Africa
[7] Univ Ferrara, ENT Dept, I-44100 Ferrara, Italy
[8] Univ Gothenburg, Dept Audiol, Gothenburg, Sweden
[9] Univ Iowa, Dept Otolaryngol Head & Neck Surg, Mol Otolaryngol Res Labs, Iowa City, IA 52242 USA
关键词
D O I
10.1086/302855
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Usher syndrome type IIa (USHIIa) is an autosomal recessive disorder characterized by moderate to severe sensorineural hearing loss and progressive retinitis pigmentosa, This disorder maps to human chromosome 1q41. Recently, mutations in USHIIa patients were identified in a novel gene isolated from this chromosomal region. The USH2A gene encodes a protein with a predicted molecular weight of 171.5 kD and possesses laminin epidermal growth factor as well as fibronectin type III domains. These domains are observed in other protein components of the basal lamina and extracellular matrixes; they may also be observed in cell-adhesion molecules. The intron/exon organization of the gene whose protein we name "Usherin" was determined by direct sequencing of PCR products and cloned genomic DNA with cDNA-specific primers. The gene is encoded by 21 exons and spans a minimum of 105 kb. A mutation search of 57 independent USHIIa probands was performed with a combination of direct sequencing and heteroduplex analysis of PCR-amplified exons. Fifteen new mutations were found. Of 114 independent USH2A alleles, 58 harbored probable pathologic mutations. Ten cases of USHIIa were true homozygotes and 10 were compound heterozygotes; 18 heterozygotes with only one identifiable mutation were observed. Sixty-five percent (38/58) of cases had at least one mutation, and 51% (58/114) of the total number of possible mutations were identified. The allele 2299delG (previously reported as 2314delG) was the most frequent mutant allele observed (16%; 31/192). Three new missense mutations (C319Y, N346H, and C419F) were discovered; all were restricted to the previously unreported laminin domain VI region of Usherin. The possible significance of this domain, known to be necessary for laminin network assembly, is discussed in the context of domain VI mutations from other proteins.
引用
收藏
页码:1199 / 1210
页数:12
相关论文
共 50 条
  • [21] Distribution of Usherin in humans and its effects on reproduction in people with Usher Syndrome type II.
    Pearsall, NA
    Bhattacharya, G
    Cosgrove, D
    Wisecarver, JL
    Kimberling, WJ
    AMERICAN JOURNAL OF HUMAN GENETICS, 2001, 69 (04) : 651 - 651
  • [22] Usher type IIa: Spectrum of mutations in Danish and Norwegian patients.
    Nilssen, O
    Dreyer, B
    Rosenberg, T
    Weston, MD
    Kimberling, WJ
    Tranebjaerg, L
    AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 65 (04) : A482 - A482
  • [23] Expressivity of hearing loss in cases with Usher syndrome type IIA
    Sadeghi, Andre M.
    Cohn, Edward S.
    Kimberling, William J.
    Halvarsson, Glenn
    Moller, Claes
    INTERNATIONAL JOURNAL OF AUDIOLOGY, 2013, 52 (12) : 832 - 837
  • [24] Identification of 11 novel mutations in USH2A among Japanese patients with Usher syndrome type 2
    Nakanishi, H.
    Ohtsubo, M.
    Iwasaki, S.
    Hotta, Y.
    Mizuta, K.
    Mineta, H.
    Minoshima, S.
    CLINICAL GENETICS, 2009, 76 (04) : 383 - 391
  • [25] DEFECTIVE MYOSIN VIIA GENE RESPONSIBLE FOR USHER SYNDROME TYPE 1B
    WELL, D
    BLANCHARD, S
    KAPLAN, J
    GUILFORD, P
    GIBSON, F
    WALSH, J
    MBURU, P
    VARELA, A
    LEVILLERS, J
    WESTON, MD
    KELLEY, PM
    KIMBERLING, WJ
    WAGENAAR, M
    LEVIACOBAS, F
    LARGETPIET, D
    MUNNICH, A
    STEEL, KP
    BROWN, SDM
    PETIT, C
    NATURE, 1995, 374 (6517) : 60 - 61
  • [26] Novel mutations in the USH1C gene in Usher syndrome patients
    Jose Aparisi, Maria
    Garcia-Garcia, Gema
    Jaijo, Teresa
    Rodrigo, Regina
    Graziano, Claudio
    Seri, Marco
    Simsek, Tulay
    Simsek, Enver
    Bernal, Sara
    Baiget, Montserrat
    Perez-Garrigues, Herminio
    Aller, Elena
    Maria Millan, Jose
    MOLECULAR VISION, 2010, 16 (313-19): : 2948 - 2954
  • [27] Identification of candidate regions for a novel Usher syndrome type II locus
    Ben Rebeh, Imen
    Benzina, Zeineb
    Dhouib, Houria
    Hadjamor, Imen
    Amyere, Mustapha
    Ayadi, Leila
    Turki, Khalil
    Hammami, Bouthaina
    Kmiha, Noureddine
    Kammoun, Hassen
    Hakim, Bochra
    Charfedine, Ilhem
    Vikkula, Miikka
    Ghorbel, Abdelmonem
    Ayadi, Hammadi
    Masmoudi, Saber
    MOLECULAR VISION, 2008, 14 (204): : 1719 - 1726
  • [28] Novel and Recurrent MYO7A Mutations in Usher Syndrome Type 1 and Type 2
    Rong, Weining
    Chen, Xue
    Zhao, Kanxing
    Liu, Yani
    Liu, Xiaoxing
    Ha, Shaoping
    Liu, Wenzhou
    Kang, Xiaoli
    Sheng, Xunlun
    Zhao, Chen
    PLOS ONE, 2014, 9 (05):
  • [29] Identification of two novel compound heterozygous mutations of ADGRV1 in a Chinese family with Usher syndrome type IIC
    Zhang, Nian
    Wang, Juan
    Liu, Shuting
    Liu, Mugen
    Jiang, Fagang
    OPHTHALMIC GENETICS, 2018, 39 (04) : 517 - 521
  • [30] Identification and in vitro expression of novel CDH23 mutations of patients with Usher syndrome type 1D
    Gal, A
    von Brederlow, B
    Rudolph, G
    Lorenz, B
    Bolz, H
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2002, 43 : U170 - U170